Synaptic dysfunction in ALS and FTD: anatomical and molecular changes provide insights into mechanisms of disease

被引:23
|
作者
Gelon, Pauline A. [1 ]
Dutchak, Paul A. [1 ]
Sephton, Chantelle F. [1 ]
机构
[1] Laval Univ, CERVO Brain Res Ctr, Dept Psychiat & Neurosci, Quebec City, PQ, Canada
来源
基金
加拿大自然科学与工程研究理事会;
关键词
amyotrophic lateral sclerosis (ALS; Lou Gehrig Disease); frontotemporal dementia (FTD); motor neuron disease (MND); synapse; dendrite; C9ORF72; TDP-43 (TAR DNA binding protein 43); fused in sarcoma (FUS); AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; MOTOR-NEURON DISEASE; DNA-BINDING PROTEIN; DIPEPTIDE-REPEAT PROTEINS; MESSENGER-RNA; MOUSE MODEL; HEXANUCLEOTIDE REPEAT; ALZHEIMERS-DISEASE; TARDBP MUTATIONS;
D O I
10.3389/fnmol.2022.1000183
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Synaptic loss is a pathological feature of all neurodegenerative diseases including amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). ALS is a disease of the cortical and spinal motor neurons resulting in fatal paralysis due to denervation of muscles. FTD is a form of dementia that primarily affects brain regions controlling cognition, language and behavior. Once classified as two distinct diseases, ALS and FTD are now considered as part of a common disease spectrum based on overlapping clinical, pathological and genetic evidence. At the cellular level, aggregation of common proteins and overlapping gene susceptibilities are shared in both ALS and FTD. Despite the convergence of these two fields of research, the underlying disease mechanisms remain elusive. However, recent discovers from ALS and FTD patient studies and models of ALS/FTD strongly suggests that synaptic dysfunction is an early event in the disease process and a unifying hallmark of these diseases. This review provides a summary of the reported anatomical and cellular changes that occur in cortical and spinal motor neurons in ALS and FTD tissues and models of disease. We also highlight studies that identify changes in the proteome and transcriptome of ALS and FTD models and provide a conceptual overview of the processes that contribute to synaptic dysfunction in these diseases. Due to space limitations and the vast number of publications in the ALS and FTD fields, many articles have not been discussed in this review. As such, this review focuses on the three most common shared mutations in ALS and FTD, the hexanucleuotide repeat expansion within intron 1 of chromosome 9 open reading frame 72 (C9ORF72), transactive response DNA binding protein 43 (TARDBP or TDP-43) and fused in sarcoma (FUS), with the intention of highlighting common pathways that promote synaptic dysfunction in the ALS-FTD disease spectrum.
引用
收藏
页数:26
相关论文
共 50 条
  • [1] Als and Ftd: Insights into the disease mechanisms and therapeutic targets
    Liscic, Rajka M.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2017, 817 : 2 - 6
  • [2] Molecular pathology, developmental changes and synaptic dysfunction in (pre-) symptomatic human C9ORF72-ALS/FTD cerebral organoids
    van der Geest, Astrid T.
    Jakobs, Channa E.
    Ljubikj, Tijana
    Huffels, Christiaan F. M.
    Luna, Marta Canizares
    de Sa, Renata Vieira
    Adolfs, Youri
    de Wit, Marina
    Rutten, Daan H.
    Kaal, Marthe
    Zwartkruis, Maria M.
    Carcole, Mireia
    Groen, Ewout J. N.
    Hol, Elly M.
    Basak, Onur
    Isaacs, Adrian M.
    Westeneng, Henk-Jan
    van den Berg, Leonard H.
    Veldink, Jan H.
    Schlegel, Domino K.
    Pasterkamp, R. Jeroen
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2024, 12 (01):
  • [3] Synaptic dysfunction and altered excitability in C90RF72 ALS/FTD
    Starr, Alexander
    Sattler, Rita
    BRAIN RESEARCH, 2018, 1693 : 98 - 108
  • [4] Phenotypic Suppression of ALS/FTD-Associated Neurodegeneration Highlights Mechanisms of Dysfunction
    Bartoletti, Mathieu
    Bosco, Daryl A.
    Da Cruz, Sandrine
    Lagier-Tourenne, Clotilde
    Liachko, Nicole
    Markmiller, Sebastian
    Webster, Kristin M.
    Wharton, Kristi A.
    JOURNAL OF NEUROSCIENCE, 2019, 39 (42): : 8217 - 8224
  • [5] Neuroinflammation and ALS: Transcriptomic Insights into Molecular Disease Mechanisms and Therapeutic Targets
    Morello, Giovanna
    Spampinato, Antonio Gianmaria
    Cavallaro, Sebastiano
    MEDIATORS OF INFLAMMATION, 2017, 2017
  • [6] The Role of Glial Cells in Synaptic Dysfunction: Insights into Alzheimer's Disease Mechanisms
    Yu, Yang
    Chen, Ran
    Mao, Kaiyue
    Deng, Maoyan
    Li, Zhigang
    AGING AND DISEASE, 2024, 15 (02): : 459 - 479
  • [7] Molecular Mechanisms Linking ALS/FTD and Psychiatric Disorders, the Potential Effects of Lithium
    Limanaqi, Fiona
    Biagioni, Francesca
    Ryskalin, Larisa
    Busceti, Carla L.
    Fornai, Francesco
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2019, 13
  • [8] Neuropathologic Changes Provide Insights into Key Mechanisms of Alzheimer Disease and Related Dementia
    Plascencia-Villa, German
    Perry, George
    AMERICAN JOURNAL OF PATHOLOGY, 2022, 192 (10): : 1340 - 1346
  • [9] MECHANISMS OF SYNAPTIC DYSFUNCTION IN ALZHEIMERS-DISEASE
    MASLIAH, E
    HISTOLOGY AND HISTOPATHOLOGY, 1995, 10 (02) : 509 - 519
  • [10] Insights into the molecular mechanisms of synaptic vesicle docking and fusion
    Ting, AE
    Scheller, RH
    COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY, 1995, 60 : 361 - 369